ORBIMED ADVISORS LLC
SEC insider (Form 3/4/5 filer). CIK 0001055951. Director & 10% Owner at ADARx Pharmaceuticals, Inc. (ADRX) and 9 other issuers. 152 reported Form 4/5 transactions since Sep 2024; latest on Sep 21, 2026. Located in NEW YORK, NY.
Companies ORBIMED ADVISORS LLC has filed insider reports for
- ADARx Pharmaceuticals, Inc. (ADRX): Director, 10% Owner
- Electra Therapeutics, Inc. (ETRA): Director
- BlossomHill Therapeutics, Inc. (BLSM): Director
- Braveheart Bio, Inc. (BRVE): Director, 10% Owner
- Yarrow Bioscience, Inc. (YARW): Director
- Scribe Therapeutics, Inc. (SCTX): Director
- Sionna Therapeutics, Inc. (SION): Director
- Enliven Therapeutics, Inc. (ELVN): 10% Owner
- Shattuck Labs, Inc. (STTK): Director
- Q32 Bio Inc. (QTTB): Director, 10% Owner
ORBIMED ADVISORS LLC
CIK: 0001055951
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (27)
ADARx Pharmaceuticals, Inc.
Electra Therapeutics, Inc.
BlossomHill Therapeutics, Inc.
Braveheart Bio, Inc.
Yarrow Bioscience, Inc.
Scribe Therapeutics, Inc.
Sionna Therapeutics, Inc.
Enliven Therapeutics, Inc.
Shattuck Labs, Inc.
Q32 Bio Inc.
Traws Pharma, Inc.
Prelude Therapeutics Inc
ImageneBio, Inc.
Adicet Bio, Inc.
Keros Therapeutics, Inc.
PMV Pharmaceuticals, Inc.
Turnstone Biologics Corp.
Corvus Pharmaceuticals, Inc.
Passage BIO, Inc.
NeuroPace Inc
Xtant Medical Holdings, Inc.
Compass Therapeutics, Inc.
Edgewise Therapeutics, Inc.
Disc Medicine, Inc.
MBX Biosciences, Inc.
Lomond Therapeutics Holdings, Inc.
Upstream Bio, Inc.
Discretionary Trading P&L
Holdings
Transaction History (152 total)
- Sep 21, 2026ETRA
Electra Therapeutics, Inc.
PurchaseIndirect1M shares at avg. $15.00$15.0M - Sep 21, 2026ETRA
Electra Therapeutics, Inc.
ConversionIndirect2M shares- - Sep 21, 2026ETRA
Electra Therapeutics, Inc.
PurchaseIndirect333.3K shares at avg. $15.00$5.0M - Sep 21, 2026ETRA
Electra Therapeutics, Inc.
ConversionIndirect758.3K shares- - Sep 21, 2026ETRA
Electra Therapeutics, Inc.
ConversionIndirect1.1M shares- - Sep 21, 2026ETRA
Electra Therapeutics, Inc.
ConversionIndirect1.7M shares- - Aug 10, 2026BLSM
BlossomHill Therapeutics, Inc.
ConversionIndirect1M shares- - Aug 10, 2026BLSM
BlossomHill Therapeutics, Inc.
ConversionIndirect1M shares- - Aug 10, 2026BLSM
BlossomHill Therapeutics, Inc.
PurchaseIndirect625K shares at avg. $16.00$10.0M - Aug 7, 2026BRVE
Braveheart Bio, Inc.
PurchaseIndirect1.7M shares at avg. $18.00$30.0M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc. | Purchase | 1,000,000 | $15.00 | $15,000,000 | Indirect |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc. | Conversion | 2,002,310 | - | $0 | Indirect |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc. | Purchase | 333,333 | $15.00 | $4,999,995 | Indirect |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc. | Conversion | 758,279 | - | $0 | Indirect |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc. | Conversion | 1,087,934 | - | $0 | Indirect |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc. | Conversion | 1,703,314 | - | $0 | Indirect |
| Aug 10, 2026 | BLSM BlossomHill Therapeutics, Inc. | Conversion | 1,039,996 | - | $0 | Indirect |
| Aug 10, 2026 | BLSM BlossomHill Therapeutics, Inc. | Conversion | 1,049,283 | - | $0 | Indirect |
| Aug 10, 2026 | BLSM BlossomHill Therapeutics, Inc. | Purchase | 625,000 | $16.00 | $10,000,000 | Indirect |
| Aug 7, 2026 | BRVE Braveheart Bio, Inc. | Purchase | 1,666,667 | $18.00 | $30,000,006 | Indirect |
1-10 of 152 transactions